Opko Health (OPK) Liabilities and Shareholders Equity (2016 - 2025)
Opko Health (OPK) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $1.9 billion as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Liabilities and Shareholders Equity fell 12.19% year-over-year to $1.9 billion, compared with a TTM value of $8.0 billion through Dec 2025, down 4.54%, and an annual FY2025 reading of $1.9 billion, down 12.19% over the prior year.
- Liabilities and Shareholders Equity was $1.9 billion for Q4 2025 at Opko Health, down from $2.0 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $2.5 billion in Q1 2021 and bottomed at $1.9 billion in Q4 2025.
- Average Liabilities and Shareholders Equity over 5 years is $2.2 billion, with a median of $2.2 billion recorded in 2022.
- The sharpest move saw Liabilities and Shareholders Equity increased 9.7% in 2024, then dropped 12.19% in 2025.
- Year by year, Liabilities and Shareholders Equity stood at $2.4 billion in 2021, then decreased by 9.69% to $2.2 billion in 2022, then decreased by 7.18% to $2.0 billion in 2023, then rose by 9.37% to $2.2 billion in 2024, then decreased by 12.19% to $1.9 billion in 2025.
- Business Quant data shows Liabilities and Shareholders Equity for OPK at $1.9 billion in Q4 2025, $2.0 billion in Q3 2025, and $2.0 billion in Q2 2025.